We were delighted to have been part the important discussion on unblocking the potential of collaboration at this year’s BioPharma Ambition.
Session participants included (l to r) Dr Muhammed Ali, Executive Director, Regional Healthcare Solutions Strategy, MSD International; Dr Richard L. Schilsky, Senior Vice PresidenWe were delighted to have been part the important discussion on unblocking the potential of collaboration at this year’s BioPharma Ambition. Session participants included (l to r) Dr Muhammed Ali, Executive Director, Regional Healthcare Solutions Strategy, MSD International; Dr Richard L. Schilsky, Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO); Eibhlín Mulroe, CEO, Cancer Trials Ireland and session Chair; Dr Caitriona Creely, Programme Manager; Dr Pat O’ Mahony, Chief Executive, Clinical Research Development Ireland (CRDI) and Prof Bryan Hennessy, Clinical Lead, Cancer Trials Irelandt and Chief Medical Officer, American Society of Clinical Oncology (ASCO); Eibhlín Mulroe, CEO, Cancer Trials Ireland and session Chair; Dr Caitriona Creely, Programme Manager; Dr Pat O’ Mahony, Chief Executive, Clinical Research Development Ireland (CRDI) and Prof Bryan Hennessy, Clinical Lead, Cancer Trials Ireland